Blood cancer infection prevention showdown: immunoglobulin vs. antibiotics

NCT ID NCT07202091

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times

Summary

This study looks at different ways to prevent serious infections in people with blood cancers like myeloma, leukemia, and lymphoma. About 900 participants who have been on immunoglobulin therapy for at least 6 months will either stop it, switch to antibiotics, or continue current care. The goal is to see which approach works best to keep patients infection-free and reduce hospital visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Austin Hospital

    RECRUITING

    Melbourne, Victoria, 3004, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Northern Health

    RECRUITING

    Melbourne, Victoria, 3004, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Royal Adelaide Hospital

    RECRUITING

    Adelaide, South Australia, 5000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.